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ABSTRACT Noroviruses are the leading cause of acute gastroenteritis in all age
groups and constitute a major health and economic burden worldwide. This system-
atic review and meta-analysis aimed to determine the diagnostic accuracy of immu-
nochromatographic tests (ICTs) for the detection of norovirus in stool specimens,
which has not been performed previously. In this systematic review and meta-analy-
sis (registered on PROSPERO, CRD42020186911), we searched Medline/PubMed,
Embase, Cochrane Library, and Web of Science for all studies published up to 16
May 2020. The values for sensitivity, specificity, positive likelihood ratio (LR1), nega-
tive likelihood ratio (LR2), and diagnostic odds ratio (DOR) of ICTs with 95% confi-
dence interval (CI) were pooled using a bivariate random-effects model. The sum-
mary receiver operating characteristic curve and area under the curve were used to
summarize overall test accuracy. We included 43 studies describing 7,428 samples.
The overall estimates of sensitivity, specificity, LR1, LR2, DOR, and accuracy of ICT
for diagnosing norovirus were 0.61 (95% CI, 0.54 to 0.67), 0.97 (95% CI, 0.95 to 0.98),
17.08 (95% CI, 11.15 to 26.18), 0.40 (95% CI, 0.34 to 0.46), 53.9 (95% CI, 31.32 to
92.78), and 0.928, respectively. Significant differences in pooled sensitivities were
noted between age groups and in pooled DOR and LR1 between genogroups of
included samples. ICT provides low sensitivity but high specificity and accuracy for
detecting norovirus. Thus, an ICT for norovirus can be a rapid and convenient way
for identifying patients early; however, a negative result cannot rule out norovirus
infection and should be confirmed by a reference test.
KEYWORDS diagnosis, immunochromatographic tests, meta-analysis, noroviruses,
rapid tests, systematic review
Norovirus is the leading cause of acute gastroenteritis in all age groups (1, 2) andconstitutes a major health and economic burden worldwide (3). Globally, it causes
acute gastroenteritis in approximately 20% to 24% of community or outpatient clinic
patients and 17% of hospitalized patients and 70,000 to 210,000 deaths annually (2,
4–7). Noroviruses are small, nonenveloped, positive-sense single-stranded RNA viruses
that belong to the family Caliciviridae (8). Noroviruses can be classified into 10 gen-
ogroups (GI to GX) according to the amino acid sequence diversity of the major capsid
protein VP1 and can further be divided into 49 genotypes (9). So far, GI, GII, GIV, GVIII,
and GIX are known as human pathogens (9, 10). Noroviruses are extremely contagious
because of their low infectious doses ($18 viral particles) (11). Human noroviruses are
transmitted primarily through the fecal-oral route, either through contaminated water
or food, direct person-to-person contact, or fomites and airborne droplets from vomit
(11, 12). These characteristics enable norovirus to spread rapidly (13). Additionally, some
populations are at high risk of norovirus infection and severe complications: young
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children, the elderly, those dwelling in group settings (e.g., military), and immunocompro-
mised individuals. Rapid detection of norovirus enables prevention and control of the out-
break, particularly for the high-risk group (14). Furthermore, prompt diagnosis of norovirus
infection could be specifically helpful during the coronavirus disease pandemic because di-
arrhea is a common symptom of severe acute respiratory syndrome coronavirus-2 infec-
tion (15), which can also be an initial presenting symptom of norovirus infection.
Currently, the gold standard for norovirus diagnosis is reverse transcription-PCR
(RT-PCR) or real-time RT-PCR (rRT-PCR) (8). However, being technically demanding,
time consuming, and expensive, their use is limited to the patient ward or outpatient
setting (16). The immunochromatographic test (ICT), also known as lateral flow assay,
is one of the most popular point-of-care tests with antigen-antibody reactions on the
membrane (17–21). ICT has several advantages such as simplicity, low cost, portability,
and rapid assay time (within 5 to 15 min) and provides dichotomous answers detected
using the naked eye (21–25). ICT targeting norovirus antigen has been developed and
commercially used. However, systematic research on the performance of ICT for
detecting norovirus in stool specimens has not yet been conducted. Thus, we per-
formed this meta-analysis to synthesize and establish the diagnostic accuracy of ICT
for norovirus infection.
RESULTS
Overall, 185 articles were retrieved, and 48 articles underwent full-text review after
removing duplicates and excluding articles based on the titles and abstracts. Twenty-
one studies were excluded: 16 studies did not provide sufficient data for 2 by 2 contin-
gency tables, two studies were not regarding norovirus, and the other three studies
did not use ICT as the index test. The remaining 27 articles were eligible for data
extraction, of which eight articles comprising 24 different sets of data using different
brands of index tests or types of specimens (e.g., frozen or unfrozen) were provided
with full 2 by 2 table information; thus, they were regarded as separate studies.
Therefore, 43 studies comprising 7,428 samples were finally included in the systematic
review and meta-analysis (Fig. 1) (16, 26–51).
The summary characteristics of all the included studies are demonstrated in
Table 1. Studies were published between 2003 and 2020 and were conducted in the
following countries: France (n=7), Japan (n=7), Thailand (n= 7), Australia (n=5), and
the United Kingdom (n=5). Fourteen studies (32.6%) included only children, four stud-
ies (9.3%) included only adults, and three studies (7.0%) included both adults and chil-
dren. The remaining studies (n=22, 51.2%) did not specifically describe the age of the
included participants. Most of the samples used in the studies included both GI and GII
(n=30, 69.8%), except one study (2.3%) that did not demonstrate the included gen-
ogroup; 11 studies included only GII (25.6%), and one study included only GI (2.3%).
The number of studies in which frozen samples were used for both the index test and
reference standard was 14 (32.6%), and the number with unfrozen samples was four
(9.3%). The remaining studies (58.1%) used mixed samples or did not specify whether
the samples were frozen or not. Among the ICTs, RIDA QUICK (R-Biopharm AG,
Darmstadt, Germany) was assessed most frequently in the included studies (n=19,
44.2%), consisting of 3,095 samples. Regarding the reference standard, most studies
(n=26, 60.5%) used RT-PCR as the reference standard, followed by rRT-PCR (n=15,
34.9%) and RT-nested PCR (n=2, 4.7%). Most studies did not describe the duration of
symptoms before testing.
The methodological quality of the included studies is demonstrated in Fig. 2.
Regarding the risk of bias in patient selection, 62.8% of the studies had a “high” risk of
bias because most studies did not clarify how they enrolled patients, whether consecu-
tively or randomly; additionally, a diagnostic case-control design (e.g., norovirus infec-
tion status was already revealed using the reference standard, and samples were sub-
sequently selected before the index test was performed) was used (52). Most studies
(90.7%) had an “unclear” risk of bias in the index test domain, since the blinding of
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personnel who conducted the index test to the results of the reference test was not
clarified. All studies were scored as “low” risk of bias, since RT-PCR or rRT-PCR was used
for diagnosing norovirus infection. Regarding the flow and timing domain, we scored
as “low” risk of bias if the interval between the index test and reference test was within
24 h. Half of the studies (51.2%) were at “low” risk and 44.2% were at “unclear” risk,
since the authors did not clarify the specific interval time. Applicability of studies was
scored as low concern for all studies.
The sensitivities and specificities of the included studies ranged from 0.105 to 1.00
and from 0.750 to 1.00, respectively (see Fig. S1 and S2 and Table S1 in the supplemen-
tal material). The overall sensitivity of each study estimated from the bivariate random-
effects model was 0.609 (95% confidence interval [CI], 0.542 to 0.673), and the specific-
ity was 0.967 (95% CI, 0.951 to 0.978). The diagnostic odds ratio (DOR) was 53.901 (95%
CI, 31.316 to 92.776). The positive likelihood ratio (LR1) and negative likelihood ratio
(LR2) were 17.082 (95% CI, 11.145 to 26.182) and 0.399 (95% CI, 0.343 to 0.464),
respectively (Table 2; see also Table S1). The area under the curve (AUC) of the sum-
mary receiver operating characteristic (SROC) curve was 0.928 (Fig. 3). The symmetrical
funnel plot, Begg’s test (P = 0.645), and Egger’s regression test (P = 0.281) revealed no
publication bias (see Fig. S3).
Substantial heterogeneity was found in both sensitivity (I2 = 90.9% [95% CI, 88.6%
to 92.7%]; P value of Q, ,0.001) and specificity (I2 = 61.9% [95% CI, 47.0% to 72.6%]; P
value of Q, ,0.001) (Fig. S1 and S2). We investigated the potential sources of
FIG 1 Flow diagram demonstrating study selection.
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heterogeneity using subgroup analysis and meta-regression for DOR. The summary
estimates for each subgroup are presented in Table 2. Significant differences in pooled
sensitivities were noted between the population’s ages; pooled DORs and LR1 values
between genogroups of included samples. The frozen/thawing step and the brand of
index test (e.g., RIDA QUICK versus others) did not affect the performance of the ICT
(Table 2). In meta-regression analysis, the population’s age and type of specimen were
a significant source of heterogeneity (P, 0.05) (Table S2).
DISCUSSION
To our knowledge, this is the first systematic review with meta-analysis evaluating
the diagnostic performance of ICT for norovirus infection. Our review demonstrates
that ICT possesses low sensitivity (0.609) but high specificity (0.967) and diagnostic ac-
curacy (0.928) for the detection of norovirus in stool specimens. These results indicate
that a positive test result is unlikely to be false positive (40, 53). Therefore, with a posi-
tive ICT result in a patient with symptoms, physicians can diagnose norovirus infection
with conviction and can initiate appropriate infection control management. However,
a negative ICT result cannot rule out the presence of norovirus definitively (53) and
needs to be further confirmed using a reference standard test if test results can affect
the decision of individual management. The following are the principal advantages of
an ICT assay: inexpensive, rapid testing, and accessibility without the need for special
skills and equipment (48). These advantages enable early and easy diagnosis in emer-
gency rooms or resource-limited settings, such as private clinics and nursing homes (8,
54, 55). Furthermore, ICT can be useful in situations where multiple samples need to
be tested, such as an outbreak setting (56).
Considerable heterogeneity in the performance of ICTs existed in our analysis.
Among the presumed factors, age groups and norovirus genogroups showed signifi-
cant differences in the performance of ICTs. However, the numbers of studies within
each subgroup were low, and several samples were categorized in the not available (NA)
group owing to limited information; thus, the results should be carefully interpreted.
The population’s age was also one of the significant heterogeneity sources in meta-
regression analysis. In a previous hospital-based, 2-year observational study, Chan et
al. (57) reported that norovirus load inversed with increasing age: young children
(#5 years) showed significantly higher viral loads for both GII.4 and non-GII.4 than
older children (.5 years). The authors suspected that a previous norovirus infection
might have resulted in partial immunity (57). This difference in viral load concentration
might have led to the difference in sensitivity between different age groups.
Additionally, clinical studies evaluating ICT focusing on the adult population (n=4)
were also limited in our analysis; thus, further studies evaluating the accuracy of ICT
FIG 2 Quality assessment of enrolled studies using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool.
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between different age groups are required. Moreover, most studies did not demon-
strate the influence of age among the included patients (n=22, 51.2%), which limits
the ability to fully explain study heterogeneity based on age groups.
Interestingly, an increase in the sensitivity of ICT through the freeze-thaw process
has been reported by several studies (29, 35, 40, 41). It is speculated the freeze-thaw
step might expose the inner epitopes and eliminate inhibitors from stool suspension
(29). The sample type, whether frozen or unfrozen, was another significant heterogene-
ity factor in the meta-regression; however, pooled sensitivity and specificity of ICTs
were not significantly different in the subgroup analysis. Again, there was a limitation
that most studies (n=25, 58.1%) used a mixture of frozen and nonfrozen samples or
the unification of the index test and reference test samples were not achieved; thus,
the results should be interpreted carefully.
There were significant differences in pooled LR1 and DOR of ICT values between
genogroups. Especially, pooled LR1 (27.20) and DOR (98.89) of ICT for GII showed the
highest value. In several previous studies, the RIDA QUICK ICT test did not detect GI;
however, only a few specimens were included (GI, n ,10) (33, 35). Battaglioli et al. (36)
reported that the sensitivity of ICT for GI (n=37) was 42.1%, and the sensitivity for GII
(n=43) was 76%, whereas the specificity for both was 100%. Although the sensitivity
of ICT for GI was low in previous studies, the sensitivity for GII was generally fair; GII
(mostly the GII.4 genotype) has been the most common genogroup worldwide fol-
lowed by GI and GIV (58–62). Specifically, the prevalence of GII accounts for approxi-
mately 96%, GI accounts for 3.6%, and mixed infections of both GI and GII account for
0.4% in children (63). A recent review of studies published from 1997 to 2018 that
detected norovirus genogroups in eight low-income and 21 low-to-middle-income
countries revealed that the prevalence of norovirus GII was much higher than that of
GI in symptomatic infections (83% to 87% versus 12% to 13%) (64); thus, ICT can still
be considered useful in clinical practice (36).
FIG 3 Summary receiver operating characteristic (SROC) curves of the diagnostic accuracy of
immunochromatographic tests (ICT) for norovirus infection. Summary points of the sensitivity and
specificity, SROC curve, 95% confidence region, and 95% prediction region are provided. The area
under the curve of the SROC for ICT was 0.928.
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Most index tests included in our review used a commercially available kit, the RIDA
QUICK (44.2%), and the performance of ICTs was not significantly different between
other ICT brands. There were two head-to-head studies comparing commercial ICT kits
(40, 44). Ambert-Balay et al. (40) evaluated four ICT kits: RIDA QUICK, ImmunoCard
STAT! (Meridian Bioscience Europe, Nice, France), NOROTOP1 (Pro-Lab Diagnostics,
Bromborough, UK), and SD BIOLINE (Standard Diagnostics, Inc., Kyonggi-do, Republic
of Korea). Among these four tests, RIDA QUICK showed the lowest sensitivity for the
detection of norovirus GI on thawed samples (0.17) but showed the highest sensitivity
(0.64) for GII. Furthermore, the sensitivity of RIDA QUICK was increased to 78% for the
GII.4 strain, which is the most prevalent genotype globally. The specificities of all tests
were 100%, with no cross-reactivity against other enteric viruses. Vyas et al. (44) also
compared five commercial ICTs: RIDA QUICK, ImmunoCard STAT!, NOROTOP1,
Immunoquick (Quadratech Diagnostics Ltd., Epsom, UK), and Noroscreen (Microgen
Bioproducts Ltd., Camberley, UK). RIDA QUICK showed the highest overall sensitivity
(0.59) and specificity (1.0). While the specificities were generally high, the RIDA QUICK
showed poorer sensitivity for detecting GI than for detecting GII (33, 35, 36). The
updated RIDA QUICK (N1402) assay is now available, which can detect broader geno-
types successfully (e.g., GI.2, GI.4, GII.6, and GII.7) (48). The N1402 version has demon-
strated high sensitivity of 0.73 to 1.0 and specificity of 0.97 to 1.0 (16, 43, 48) in several
studies. Notably, the N1402 version detected 93% of GI and 98% of GII norovirus (43),
which greatly increased the sensitivity for the GI strain.
In our review, the performances of ICTs, whether using RT-PCR or rRT-PCR as a refer-
ence standard, were not significantly different. Generally, rRT-PCR can detect and quan-
tify norovirus genomes, which provides rapid results and reduces the risk of carryover
contamination (38, 39). However, the sensitivity and specificity of rRT-PCR can vary, since
noroviruses have very highly diverse genomes and different rRT-PCR protocols utilize dif-
ferent primers or probes and reagents and have different reaction conditions (65–68).
Our study has several limitations. First, most studies did not provide clinical data
such as the comorbidity of included patients or the time interval between the onset of
symptoms and testing. Second, we could not compare the pooled estimates of ICT per-
formance between specific genotypes due to the limited number of clinical studies
that provided those data. Third, we could not evaluate the effects of industrial sponsor-
ship and blinding of testing through meta-analysis, because most included studies did
not provide that information. Although several studies showed that the updated RIDA
QUICK (N1402) assay can detect broader genotypes and increase the diagnostic per-
formance for the GI strain, the subgroup analysis according to the RIDA QUICK versions
was limited due to the insufficient number of studies and the studies that used differ-
ent RIDA QUICK versions as an index test concomitantly. Further studies are required
to ensure the applicability of the results of studies of ICTs conducted in various clinical
settings and explore the performance of the N1402 version of the RIDA QUICK assay.
In conclusion, ICT is a simple, fast, and reliable method with low sensitivity, high
specificity, and accuracy for norovirus detection. Thus, if clinicians are aware of false
negativity, ICT could function as a good axillary modality to prevent norovirus out-
breaks and could help make decisions for appropriate patient management.
MATERIALS ANDMETHODS
Search strategy and selection criteria. This systematic review and meta-analysis was conducted
according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) state-
ment (69) guidelines and was registered at the International Prospective Register of Systematic Reviews
(PROSPERO; record CRD42020186911). A systematic search of PubMed, Embase, Cochrane Library data-
base, and Web of Science was conducted with the keywords “norovirus,” “immunochromatography,”
and “lateral flow assay” on 16 May 2020. Additional eligible studies were identified from the reference lists
of the included studies. There were no date restrictions for the searches. Studies were included if they eval-
uated the accuracy of an ICT for the detection of norovirus and provided enough information for construct-
ing a 2 by 2 table. Studies in which RT-PCR or rRT-PCR served as the reference standard were considered eli-
gible. We included studies using rectal swabs when rectal swab specimens were properly collected in a
standardized manner with a flocked swab and used as standard tool of a norovirus ICTs and other swab
specimens were concomitantly collected and washed (soaked) in sterile saline or a transportation medium
Yoon et al.














































and then preserved properly for the reference standard, RT-PCR or rRT-PCR. Reviews, case reports, editorials,
conference abstracts, letters, and in vitro or animal experiments were excluded.
Two independent reviewers (S.H.Y. and J.G.A.) undertook title and abstract screening, followed by
full-text review. Disagreements between reviewers were resolved through discussion or arbitration by a
third reviewer (H.R.K.). The author names, country, year of publication, included norovirus genogroup,
population (children [aged #18 years] and adult [aged $19 years]), sample size, index test assay, refer-
ence standard, type of specimens (frozen or unfrozen or mixed [frozen with unfrozen] specimen for
index and reference tests), and the values for true positive, false positive, true negative, and false nega-
tive were extracted. Samples that initially came out as false positives but were later found to be true pos-
itives using other RT-PCR protocols were counted as true positives. When articles included multiple
study groups, each group was regarded as a separate study.
Data analysis. Pooled estimates of sensitivity, specificity, positive likelihood ratio (LR1), negative
likelihood ratio (LR2), and diagnostic odds ratio (DOR) along with their 95% confidence intervals (CIs)
were calculated using the bivariate random-effects models (70, 71). LR1 is the probability of positivity in
a patient over the probability of positivity in a participant without the disease (72, 73). DOR is the ratio
of the odds of positivity in participants with the disease to the odds of positivity in participants without
the disease, with higher values indicating better discriminatory power of the diagnostic test (73, 74). The
area under the curve (AUC) based on the summary receiver operating characteristic (SROC) curve was
obtained to summarize the overall test accuracy. We added a fixed value (0.5) to all zero cells in 2 by 2
tables as a continuity correction.
Heterogeneity was evaluated using Cochran’s Q test (P , 0.1, significant heterogeneity), I2 metric
(0% to 24%, low; 25% to 74%, moderate; and 75% to 100%, considerable heterogeneity), and visual
inspection of forest plots. With significant heterogeneity, we conducted subgroup analysis and meta-
regression analysis for assessing heterogeneity with 95% CIs using the following as covariates: age of
the population (adults, children, and adults and children), genogroup (GI and GII versus GII), type of
specimen (frozen versus unfrozen: we classified frozen specimen when both the index test sample and
reference test sample were frozen; unfrozen specimen was defined when both samples were unfrozen),
index test brand (RIDA QUICK versus others), and reference test (RT-PCR versus rRT-PCR) used. We classi-
fied RT-nested PCR as RT-PCR when performing meta-regression. Publication bias was assessed using
the Begg’s test (75), Egger’s regression test (76), and asymmetry of funnel plots (77, 78). The Quality
Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool was used for evaluating the validity of
the included studies (79). The QUADAS-2 tool comprises four domains: patient selection, index test, refer-
ence standard, and flow and timing. The domains were assessed for risk of bias and applicability. Two
authors independently performed the quality assessment, and disagreements between them were resolved
by a consensus. R statistical software (version 3.4.3; R Foundation for Statistical Computing, Vienna, Austria)
was used for performing meta-analyses. P values of,0.05 were considered statistically significant.
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